Yabao Pharmaceutical announced that the company received a notice from the controlling shareholder Shanxi Yabao Investment Group Co., Ltd. to carry out a stock pledged repurchase transaction. Before this pledge, Yabao Investment pledged a total of 26.85 million shares, and after this pledge, it pledged a total of 38.45 million shares, accounting for 40.77% of the total number of shares held in the company and 5.56% of the company's total share capital. Yabao Investment holds 94.3 million shares of the company, accounting for 13.63% of the company's total share capital. The shares pledged this time are not used as a guarantee or other guarantee for matters such as compensation for major asset restructuring performance.

Yabao Pharmaceutical announced that the company received a notice from the controlling shareholder Shanxi Yabao Investment Group Co., Ltd. to carry out a stock pledged repurchase transaction. Before this pledge, Yabao Investment pledged a total of 26.85 million shares, and after this pledge, it pledged a total of 38.45 million shares, accounting for 40.77% of the total number of shares held in the company and 5.56% of the company's total share capital. Yabao Investment holds 94.3 million shares of the company, accounting for 13.63% of the company's total share capital. The shares pledged this time are not used as a guarantee or other guarantee for matters such as compensation for major asset restructuring performance.